NCT01880034

Brief Summary

Significant data exists to suggest that lipid emulsion administration in the setting of local anesthetic toxicity has the potential to be life-saving. Unfortunately, a variety of potential barriers exist to routine lipid emulsion administration for those performing regional anesthesia including drug availability, drug cost and drug location. Inadequate training or lack of established protocols also have the potential to negatively impact patient outcomes. A previous study by Toledo et al (Availability of lipid emulsion in United States obstetric units. Anesth Analg 2013;116:406-408.) evaluated lipid emulsion availability on obstetric units and found that it was nearly universally available. The Accreditation Council for Graduate Medical Education (ACGME) publishes a list of contact information for each anesthesia institution that engages in resident training. Investigators will contact these institutions by phone or email to obtain contact information for their regional anesthesia program director. In the absence of a program director, investigators will send a survey and consent information via email to the faculty physician most involved in regional anesthesia. Survey completion instructions (survey itself to be completed on Qualtrics Survey Hosting Service) and copy of the study consent form will be attached to the initial contact email. The study consent form will contain a description of the study itself. Survey participants will be allowed time to complete their survey in private at their discretion. Non-responders will receive two follow-up emails at one month intervals.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
18

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jun 2013

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2013

Completed
12 days until next milestone

First Submitted

Initial submission to the registry

June 13, 2013

Completed
5 days until next milestone

First Posted

Study publicly available on registry

June 18, 2013

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2014

Completed
Last Updated

May 12, 2017

Status Verified

May 1, 2017

Enrollment Period

1.5 years

First QC Date

June 13, 2013

Last Update Submit

May 11, 2017

Conditions

Outcome Measures

Primary Outcomes (1)

  • Is lipid emulsion available at all locations where regional anesthesia is practiced in your institution?

    Survey options include 1. Yes, lipid emulsion is available in the room where regional anesthesia is performed. 2. Yes, lipid emulsion is available in a near-by pharmacy 3. Yes, lipid emulsion is available in a central pharmacy 4. No, lipid emulsion is not available in all locations where regional anesthesia is performed

    Two months

Secondary Outcomes (1)

  • If lipid emulsion is available to those practicing regional anesthesia at your institution, how long would it take to obtain it?

    Two Months.

Study Arms (1)

Regional Anesthesia Section Heads

This group will consist of Regional Anesthesia Section Heads at anesthesia residency training programs.

Other: Lipid Emulsion Survey

Interventions

Regional Anesthesia Section Heads

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Regional Anesthesia Section heads at academic anesthesia institutions.

You may qualify if:

  • Regional Anesthesia Section heads at academic anesthesia institutions.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Wisconsin School of Medicine and Public Health

Madison, Wisconsin, 53792, United States

Location

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
OTHER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 13, 2013

First Posted

June 18, 2013

Study Start

June 1, 2013

Primary Completion

December 1, 2014

Study Completion

December 1, 2014

Last Updated

May 12, 2017

Record last verified: 2017-05

Locations